Biopharmaceutical company ImaRx Therapeutics of Tucson, AZ, is reporting that Dr. Evan Unger is stepping down from his positions as president and CEO of the company.
The firm said that Unger is resigning to spend more time on the scientific development of the company. The company's board has created an Office of the CEO and has appointed Brad Zakes, the firm's chief operating officer, and Greg Cobb, the company's chief financial officer, to staff the office on an interim basis.
By AuntMinnie.com staff writers
October 24, 2006
Related Reading
ImaRx to go public, May 22, 2006
ImaRx buys Abbokinase, May 9, 2006
ImaRx adds VP, September 8, 2005
ImaRx receives $1.1 million grant, August 2, 2005
ImaRx's SonoLysis begins phase I/II PAOD trial, April 12, 2005
Copyright © 2006 AuntMinnie.com